![IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis - ScienceDirect IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567576920327727-gr1.jpg)
IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis - ScienceDirect
![IL-17 immunity and experimental psoriasis in mouse skin. (A) Healthy... | Download Scientific Diagram IL-17 immunity and experimental psoriasis in mouse skin. (A) Healthy... | Download Scientific Diagram](https://www.researchgate.net/profile/Sigrun-Hofmann/publication/352470930/figure/fig2/AS:1108159603183632@1641217246100/CD4-T-cells-from-patients-with-psoriasis-express-increased-levels-of-CREMa_Q320.jpg)
IL-17 immunity and experimental psoriasis in mouse skin. (A) Healthy... | Download Scientific Diagram
![Guselkumab logra altas tasas de remisión de las lesiones cutáneas de pacientes con psoriasis durante casi cinco años Guselkumab logra altas tasas de remisión de las lesiones cutáneas de pacientes con psoriasis durante casi cinco años](https://isanidad.com/wp-content/uploads/2017/11/inyeccion-efe-neg-getty-597c01405f9b58928bdb0f98.jpg)
Guselkumab logra altas tasas de remisión de las lesiones cutáneas de pacientes con psoriasis durante casi cinco años
![Peter Weisenseel's research works | Ludwig-Maximilians-University of Munich, Munich (LMU) and other places Peter Weisenseel's research works | Ludwig-Maximilians-University of Munich, Munich (LMU) and other places](https://www.researchgate.net/publication/354558353/figure/fig1/AS:1067824181149696@1631600532011/Current-pathogenic-model-of-psoriasis-2-12-14-41-65-A-T-cell-subsets-in-psoriasis_Q320.jpg)